Overall Survival According to Patient Subgroups: Results from a Pooled Analysis of 5 Observational or Phase Iv Studies of Bevacizumab in Metastatic Colorectal Cancer

Annals of Oncology - Tập 25 - Trang iv176 - 2014
A. Grothey1, D. Arnold2, E. Van Cutsem3, T. Bekaii-Saab4, M. Kozloff5, J. Bennouna6, C. Revil7, M. Donica7, N. Sommer8, B. Leutgeb9, M. Ekstrand-Olsen10, F. Hermann11, H. Hurwitz12
1Medical Oncology, Mayo Clinic, Rochester, NY, USA
2Medical Oncology, Klinik fuer Tumorbiologie, Freiburg, GERMANY
3Digestive Oncology, University Hospital Leuven and KU Leuven, Leuven, BELGIUM
4Medical Center, The Ohio State University, Columbus, OH, USA
5Hematology/oncology, Ingalls Hospital and University of Chicago, Harvey, IL, USA
6Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, FRANCE
7Global Medical Affairs Operations (biometrics), F. Hoffmann-La Roche, Ltd., Basel, SWITZERLAND
8Medical Affairs, Genentech, Inc. South San Francisco, CA, USA
9Gi-gu-neuro-oncology, F. Hoffmann-La Roche, Ltd., Basel, SWITZERLAND
10Medical Department, F. Hoffmann-La Roche, Ltd., Basel, SWITZERLAND
11Global Medical Affairs, F. Hoffmann-La Roche, Ltd., Basel, SWITZERLAND
12Gi Oncology Unit, Duke University Medical Center, Durham, NC, USA

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 25

iv176

Thông tin tác giả